Bayer bets on ‘silver bullet’ defense in Roundup litigation; experts see hurdles
NEW YORK (Reuters) – Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be…